Health
China’s cancer breakthrough on CAR-T cell therapy shows progress
Key Points
In June, Chinese regulators approved the world’s first CAR-T cell therapy for solid tumour cancers, developed by a drug company based in Shanghai. One month later, at a hospital in the city, a New Zealander with advanced cancer of the stomach and small intestine became the first international patient to receive the breakthrough treatment. Chimeric antigen receptor T-cell therapy, to give it its full name, is a cutting-edge treatment that, until then, had only been approved to treat blood...
In June, Chinese regulators approved the world’s first CAR-T cell therapy for solid tumour cancers, developed by a drug company based in Shanghai. One month later, at a hospital in the city, a New Zealander with advanced cancer of the stomach and small intestine became the first international patient to receive the breakthrough treatment.
Chimeric antigen receptor T-cell therapy, to give it its full name, is a cutting-edge treatment that, until then, had only been approved to treat blood...
[Image text:] CHINA
FUTURE
TECH
China's cancer
breakthrough on
CAR-T cell therapy
shows progress
By Paul Buck
Senior Production Editor, Hong Kong
September22,2026
In June, Chinese regulators approved the world's first CAR-T cell therapy for solid
tumour cancers, developed by a drug company based in Shanghai.One month later,
at a hospital in the city, a New Zealander with advanced cancer of the stomach and
small intestine became the first international patient to receive the breakthrough